Therapeutic strategies for critically ill patients with COVID-19

Since the 2019 novel coronavirus disease (COVID-19) outbreak originated from Wuhan, Hubei Province, China, at the end of 2019, it has become a clinical threat to the general population worldwide. Among people infected with the novel coronavirus (2019-nCoV), the intensive management of the critically...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Lei, Li, Ranran, Wu, Zhixiong, Yang, Xianghong, Zhao, Mingyan, Liu, Jiao, Chen, Dechang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167303/
https://www.ncbi.nlm.nih.gov/pubmed/32307593
http://dx.doi.org/10.1186/s13613-020-00661-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167303/
https://www.ncbi.nlm.nih.gov/pubmed/32307593
http://dx.doi.org/10.1186/s13613-020-00661-z

Ejemplares similares